Depression and Anxiety Trial, Recruiting (NCT04693858)

Depression and Anxiety Trial, Recruiting NCT04693858 Sponsor: UConn Health Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT04693858 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For children:

Children who are between 5 and 12 years old
Children who show elevated anxiety symptoms, based on a standardised anxiety questionnaire score of 15 or higher (reported by a parent and/or child), or a clinical rating of 3 or higher on any anxiety diagnosis during a structured interview
Children who are fluent in English, so they are able to complete consent forms and study materials
Children already taking medication or receiving psychological treatment may be eligible, as long as the dose or treatment has been stable for at least 4 weeks and no changes are planned during the 8-week intervention period

For school nurses:

Participants who are a Registered Nurse (RN) or a similar qualified medical professional
Participants who work in the role of a school nurse
Participants who are fluent in English

Who may not be able to join:

Children who do not meet all of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Golda S Ginsburg, Ph.D., UConn Health

Phone: 8605233788

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04693858

Sponsor: UConn Health

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 8605233788

More information: https://clinicaltrials.gov/study/NCT04693858

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For children:

Children who are between 5 and 12 years old
Children who show elevated anxiety symptoms, based on a standardised anxiety questionnaire score of 15 or higher (reported by a parent and/or child), or a clinical rating of 3 or higher on any anxiety diagnosis during a structured interview
Children who are fluent in English, so they are able to complete consent forms and study materials
Children already taking medication or receiving psychological treatment may be eligible, as long as the dose or treatment has been stable for at least 4 weeks and no changes are planned during the 8-week intervention period

For school nurses:

Participants who are a Registered Nurse (RN) or a similar qualified medical professional
Participants who work in the role of a school nurse
Participants who are fluent in English

Who may not be able to join:

Children who do not meet all of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

UConn Health

Registry

ClinicalTrials.gov

Start date

1 December 2020

Est. completion

3 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical Global Impression - Impairment (CGI-I) Scale, 8 weeks after baseline; Clinical Global Impression - Impairment (CGI-I) Scale, 12-month follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov